Mediobanca Research Maintains Neutral Rating on SOL S.p.A. Following Wentimed Acquisition
Mediobanca Research has reaffirmed its 'neutral' recommendation for SOL S.p.A. in light of the company's recent acquisition of the Polish home care provider Wentimed.